Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study

Hairy cell leukemia (HCL) is a rare lymphoproliferative disease with an excellent prognosis after treatment with cladribine (2CDA), although relapse may occur during follow-up. The aim of the study is to review the efficacy, safety, long-term remission rate, and overall survival (OS) in those patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagano, Livio, Criscuolo, Marianna, Broccoli, Alessandro, Piciocchi, Alfonso, Varettoni, Marzia, Galli, Eugenio, Anastasia, Antonella, Cantonetti, Maria, Trentin, Livio, Kovalchuk, Sofia, Orsucci, Lorella, Frustaci, Annamaria, Spolzino, Angelica, Volpetti, Stefano, Annibali, Ombretta, Storti, Sergio, Stelitano, Caterina, Marchesi, Francesco, Offidani, Massimo, Casadei, Beatrice, Nizzoli, Maria Elena, De Luca, Maria Lucia, Fianchi, Luana, Motta, Marina, Guarnera, Luca, Simonetti, Edoardo, Visentin, Andrea, Vassallo, Francesco, Deodato, Marina, Sarlo, Chiara, Olivieri, Attilio, Falini, Brunangelo, Pulsoni, Alessandro, Tiacci, Enrico, Zinzani, Pier Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296486/
https://www.ncbi.nlm.nih.gov/pubmed/35853850
http://dx.doi.org/10.1038/s41408-022-00702-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296486/
https://www.ncbi.nlm.nih.gov/pubmed/35853850
http://dx.doi.org/10.1038/s41408-022-00702-9

Ejemplares similares